| RRC ID |
57743
|
| Author |
Saito H, Tanaka T, Sugahara M, Tanaka S, Fukui K, Wakashima T, Nangaku M.
|
| Title |
Inhibition of prolyl hydroxylase domain (PHD) by JTZ-951 reduces obesity-related diseases in the liver, white adipose tissue, and kidney in mice with a high-fat diet.
|
| Journal |
Lab Invest
|
| Abstract |
The epidemic of obesity and its complications is rapidly increasing worldwide. Recent drug discoveries established the utility of prolyl hydroxylase domain (PHD) inhibitors as stabilizers of hypoxia-inducible factors (HIFs) in vivo, which are currently in human clinical studies for the treatment of anemia in chronic kidney disease (CKD). These studies suggest a role for PHD inhibitors in ameliorating obesity and hyperlipidemia. We hypothesized that HIF activation using a PHD inhibitor, JTZ-951, protects from obesity-related diseases in the white adipose tissue (WAT), liver, and kidney in mice fed with high-fat diet (HFD). Eight-week-old, C57BL/6J mice were fed with HFD for 20 weeks with or without JTZ-951(0.005%; mixed in chow). Body weight and plasma non-high-density lipoprotein (HDL) cholesterol levels were significantly lower in the JTZ-951 group as compared with the vehicle group. PHD inhibition improved liver steatosis, macrophage infiltration into WAT and adipocyte fibrosis. In the kidney, PHD inhibition reduced albuminuria. Histologically, the number of F4/80- positive infiltrating macrophages and mesangial expansion were milder in the JTZ-951 group. Relative mRNA expression of adiponectin in WAT was higher in the JTZ-951-treated group and inversely correlated with hepatic steatosis score, adipocyte macrophage aggregation, and albuminuria. Activation of HIF ameliorates multiple obesity-related consequences in mice with HFD. The results of the present study offer the promising view that pharmacological PHD inhibition may be beneficial for the treatment of obesity-related diseases that can be ameliorated by weight loss.
|
| Volume |
99(8)
|
| Pages |
1217-1232
|
| Published |
2019-7-1
|
| DOI |
10.1038/s41374-019-0239-4
|
| PII |
10.1038/s41374-019-0239-4
|
| PMID |
30952940
|
| MeSH |
Adipose Tissue, White / drug effects
Animals
Body Weight / drug effects
Diet, High-Fat*
Fatty Liver / metabolism
Kidney / drug effects
Liver / drug effects
Male
Mice
Mice, Inbred C57BL
N-substituted Glycines / pharmacology*
Obesity / metabolism*
Prolyl Hydroxylases / drug effects*
Pyridines / pharmacology*
Triazoles / pharmacology*
|
| IF |
4.197
|
| Times Cited |
5
|
| Resource |
| Human and Animal Cells |
RAW 264(RCB0535) |
